Cite
Ebong C, Sserwanga A, Namuganga JF, et al. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda. Malar J. 2021;20(1):484doi: 10.1186/s12936-021-04021-5.
Ebong, C., Sserwanga, A., Namuganga, J. F., Kapisi, J., Mpimbaza, A., Gonahasa, S., Asua, V., Gudoi, S., Kigozi, R., Tibenderana, J., Bwanika, J. B., Bosco, A., Rubahika, D., Kyabayinze, D., Opigo, J., Rutazana, D., Sebikaari, G., Belay, K., Niang, M., Halsey, E. S., Moriarty, L. F., Lucchi, N. W., Souza, S. S. S., Nsobya, S. L., Kamya, M. R., & Yeka, A. (2021). Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda. Malaria journal, 20(1), 484. https://doi.org/10.1186/s12936-021-04021-5
Ebong, Chris, et al. "Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda." Malaria journal vol. 20,1 (2021): 484. doi: https://doi.org/10.1186/s12936-021-04021-5
Ebong C, Sserwanga A, Namuganga JF, Kapisi J, Mpimbaza A, Gonahasa S, Asua V, Gudoi S, Kigozi R, Tibenderana J, Bwanika JB, Bosco A, Rubahika D, Kyabayinze D, Opigo J, Rutazana D, Sebikaari G, Belay K, Niang M, Halsey ES, Moriarty LF, Lucchi NW, Souza SSS, Nsobya SL, Kamya MR, Yeka A. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda. Malar J. 2021 Dec 24;20(1):484. doi: 10.1186/s12936-021-04021-5. PMID: 34952573.
Copy
Download .nbib